Covaxin data given to WHO for nod

Need of the hour is to give two-dose vaccine protection to adult population: ICMR.

September 30, 2021 10:30 pm | Updated October 01, 2021 11:14 am IST - NEW DELHI

NEW DELHI, 30/09/2021: A nurse administers a Covishield vaccine dose to a homeless beneficiary during the vaccination drive at night shelter Bangla Sahib Gurudwara in New Delhi on Thursday, September 30, 2021. Photo: SHIV KUMAR PUSHPAKAR / The Hindu

NEW DELHI, 30/09/2021: A nurse administers a Covishield vaccine dose to a homeless beneficiary during the vaccination drive at night shelter Bangla Sahib Gurudwara in New Delhi on Thursday, September 30, 2021. Photo: SHIV KUMAR PUSHPAKAR / The Hindu

All data for Covaxin clearance has been given to the World Health Organisation (WHO), said Indian Council of Medical Research (ICMR) Director General Dr. Balaram Bhargava at a press conference on Thursday.

Also Read:WHO decision on Covaxin EUL likely in October

The need of the hour was to give the two-dose vaccination coverage to the entire adult population. “The talk of a booster dose is not pertinent at the moment. We have had some studies where they have found antibodies persist for up to an year,” he noted.

Also Read:The importance of the booster dose to plan ahead

The Union Health Ministry stated that 69% of the adult population had received the first dose of COVID-19 vaccination, while 25 % had been given complete coverage of two doses.

Its Secretary, Rajesh Bhushan, observed, “We have seen a slow uptake of the second dose in some States and the Ministry has spoken to them about this. We also would like healthcare workers covered completely. As festivals are approaching, we appeal to all persons to avoid crowds, maintain physical distancing and use face mask. Celebrate festivals maintaining COVID-19 appropriate behaviour.”

Dr. Bhargava emphasised that it would be prudent to avoid non-essential travel and observe festivity at low-key at least this year.

Dengue vaccine

Speaking about dengue vaccine, he stressed this vaccine was an important agenda. “There are certain dengue strains which have been licensed to some companies in India. Many of these companies have done their phase one trials abroad. We are planning to do more rigorous trials,” he remarked.

Mr. Bhushan pointed to18 districts in the country reporting a weekly COVID-19 positivity between 5% and 10%, with Kerala still reporting the majority of the new cases. “Directions have been issued to the State to ensure that the festival season isn’t the reason for any spread of infection.” States have been told that mass gatherings should be avoided in areas identified as Containment Zones and in districts reporting more than 5% case positivity, he pointed out.

Also gathering with advance permissions and limited people (as per local context) to be allowed in districts with a positivity rate of 5% and below. “Relaxations and restrictions should be imposed based on weekly case positivity and avoid unnecessary travel. Celebrate online with extended family and friends,” he added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.